Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Recruiting
Observational Study
Carcinomas (Including Squamous Cell and Adenocarcinoma)
Neoplasms
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- Stanford University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to measure the levels of serum proteins and other biomarkers in cancer patients and in patients suspected of having cancer. We believe that some of these markers may be useful for confirming the diagnosis or for selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse after therapy, and survival afte…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
1. Age \> or = 18; for the samples collected under the NIH grant, no subjects below the age of 20 will be enrolled.
2. Prior diagnosis of cancer or suspected of having cancer
3. Karnofsky performance status of greater than 70
4. Standard pretreatment evaluation
5. Signed Stanford University Human Su…
Contacts
gitrialeligibility@stanford.edu gitrialeligibility@stanford.edu
650-498-7757
gitrialeligibility@stanford.edu
CONTACT